-
Medical Device Network Excellence Awards 2025: Elutia
26 Jun 2025 22:51 GMT
… the world’s first FDA-cleared drug eluting bioenvelope that combines … the embedded antibiotics—rifampin and minocycline—provide broad-spectrum protection … and commercializes drug-eluting biomatrix products to improve compatibility between medical devices …
-
Elutia Wins Dual Honors for Innovation and Product Launches at 2025 Medical Device Network Excellence Awards
26 Jun 2025 12:00 GMT
… with the antibiotics rifampin and minocycline to address CIED complications and … and commercializes drug-eluting biomatrix products to improve compatibility between medical devices … other marketing authorizations by the FDA and comparable foreign authorities …
-
Journey Medical to Join Russell 2000® and Russell 3000® Indexes
24 Jun 2025 12:30 GMT
… Drug Administration (“FDA”) approved prescription pharmaceutical products for the treatment of … Emrosi™ (40 mg Minocycline Hydrochloride Modified-Release Capsules … Fortress Biotech, Inc. (Nasdaq: FBIO). Journey Medical’s … and our clinical trials may fail to …
-
Dr Boreham’s Crucible: Can Sofdra become the ‘world’s most successful dermatology drug?’
23 Jun 2025 21:22 GMT
Botanix Pharmaceuticals (ASX:BOT) … biotech Bone Medical.
At the time, Botanix aimed for synthetic cannabinoid treatments … to 500.
“These doctors are very easily activated,” … acne treatment Solodyn (minocycline) - the most widely prescribed dermatology drug – …
-
Pluronic P123/L64 Mixed Micelles as Immediate Release Systems to Enhance the Bioavailability of Praziquantel in Rats
07 Jul 2025 11:54 GMT
… F127 (99.8%, Beyotime Biotechnology Co., Ltd., Shanghai, China … term stability, and clinical trials are warranted. Moreover, … . Preparation of a minocycline polymer micelle thermosensitive gel … effective rheumatoid arthritis treatment. Int J Pharmaceut: X. 2024 …
-
Journey Medical Corporation Announces Emrosi™ Data Analysis to be Presented at the Society of Dermatology Physician Associates (SDPA) 2025 Annual Summer Dermatology Conference
20 Jun 2025 12:30 GMT
… and Drug Administration (“FDA”) approved prescription pharmaceutical products for the treatment of dermatological … Minocycline Versus Oracea in Rosacea-2 (“MVOR-2”) Phase 3 clinical trials … by Fortress Biotech, Inc. (Nasdaq: FBIO). Journey Medical’s common …
-
Talc or Minocycline Pleurodesis May Aid managing malignant pleural effusion Management in Lung Cancer with ILD: Study
15 Jun 2025 18:08 GMT
… using talc or minocycline had potential as a treatment option for managing … of pleurodesis with talc and minocycline is about 70%. Acute respiratory …
-
Prioritizing Patient QOL in EGFR-Mutated NSCLC Treatment
12 Jun 2025 17:53 GMT
… barrier to treatment adherence in the MARIPOSA regimen. The trial aimed to … remain on their crucial treatment.
The COCOON trial enrolled 201 patients with … prophylactic plan: oral doxycycline or minocycline for 12 weeks, followed by …
-
Xediton Pharmaceuticals Inc. ('Xediton') Announced Today the Canadian Approval and Availability of Vabomere(r) (Meropenem-Vaborbactam) in Canada
13 Jun 2025 04:00 GMT
… infections with limited treatment options.
Gram-negative … Pharmaceuticals Inc.
Xediton Pharmaceuticals is a specialty pharmaceutical … and established medicines to promote … ), KIMYRSA® (oritavancin), MINOCIN® (minocycline) for Injection, ORBACTIV® (oritavancin …
-
Xediton Pharmaceuticals Inc. (Xediton) Announced Today The Canadian Approval And Availability Of Vabomere(R) (Meropenem-Vaborbactam) In Canada
13 Jun 2025 01:42 GMT
… infections with limited treatment options. Gram- … Pharmaceuticals Inc.
Xediton Pharmaceuticals is a specialty pharmaceutical … and established medicines to promote … ), KIMYRSA® (oritavancin), MINOCIN® (minocycline) for Injection, ORBACTIV® (oritavancin …